1. Home
  2. BLCO vs TFPM Comparison

BLCO vs TFPM Comparison

Compare BLCO & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • TFPM
  • Stock Information
  • Founded
  • BLCO 1853
  • TFPM 2016
  • Country
  • BLCO Canada
  • TFPM Canada
  • Employees
  • BLCO N/A
  • TFPM N/A
  • Industry
  • BLCO Ophthalmic Goods
  • TFPM Precious Metals
  • Sector
  • BLCO Health Care
  • TFPM Industrials
  • Exchange
  • BLCO Nasdaq
  • TFPM Nasdaq
  • Market Cap
  • BLCO 4.9B
  • TFPM 4.3B
  • IPO Year
  • BLCO 2022
  • TFPM N/A
  • Fundamental
  • Price
  • BLCO $13.72
  • TFPM $23.57
  • Analyst Decision
  • BLCO Hold
  • TFPM Strong Buy
  • Analyst Count
  • BLCO 13
  • TFPM 3
  • Target Price
  • BLCO $15.83
  • TFPM $23.67
  • AVG Volume (30 Days)
  • BLCO 758.1K
  • TFPM 454.2K
  • Earning Date
  • BLCO 07-30-2025
  • TFPM 08-06-2025
  • Dividend Yield
  • BLCO N/A
  • TFPM 0.94%
  • EPS Growth
  • BLCO N/A
  • TFPM N/A
  • EPS
  • BLCO N/A
  • TFPM 0.02
  • Revenue
  • BLCO $4,829,000,000.00
  • TFPM $293,708,000.00
  • Revenue This Year
  • BLCO $6.97
  • TFPM $19.66
  • Revenue Next Year
  • BLCO $5.48
  • TFPM $0.85
  • P/E Ratio
  • BLCO N/A
  • TFPM $944.68
  • Revenue Growth
  • BLCO 11.94
  • TFPM 39.01
  • 52 Week Low
  • BLCO $10.45
  • TFPM $13.94
  • 52 Week High
  • BLCO $21.69
  • TFPM $25.45
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 63.37
  • TFPM 50.15
  • Support Level
  • BLCO $12.02
  • TFPM $22.82
  • Resistance Level
  • BLCO $14.35
  • TFPM $24.15
  • Average True Range (ATR)
  • BLCO 0.45
  • TFPM 0.71
  • MACD
  • BLCO 0.06
  • TFPM -0.14
  • Stochastic Oscillator
  • BLCO 72.96
  • TFPM 41.85

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

Share on Social Networks: